RA CAPITAL MANAGEMENT, L.P. Insider Trading Activity

Also formerly known as RA CAPITAL MANAGEMENT, LLC
Average Profitability
<0.0001%
Insider Buys Quantity
148
Insider Buys Sum
$1.81B
Insider Sells Quantity
71
Insider Sells Sum
$214.98M

Insider Activity of RA CAPITAL MANAGEMENT, L.P.

According to the SEC Form 4 filings, RA CAPITAL MANAGEMENT, L.P., being in a position of

  1. 10 percent owner at Adicet Bio, Inc.,
    оver the last 12 months, has bought 223596 shares for $1.6M, and sold 0 shares,
    over all time since 2026-02-18, has bought 223596 shares for $1.6M, and sold 0 shares.

Biography of RA CAPITAL MANAGEMENT, L.P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$163,197,3003251
Sells
$209,883,6373149

Comparison of Insiders on Amount of Buys and Sells

2026-10-29SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
2.72M
8.3304%
$3.36$9.13M-12.61%
2026-09-17SaleSionna Therapeutics, Inc.
SION
3.45M
6.7355%
$6.33$21.84M-34.68%
2026-08-12SaleSepterna Inc
SEPN
1.49M
2.9211%
$42.50$63.45M-19.31%
2026-07-31PurchaseArtiva Biotherapeutics, Inc.
ARTV
24,944
0.0992%
$9.93$247,694-15.64%
2026-07-29PurchaseArtiva Biotherapeutics, Inc.
ARTV
20,824
0.084%
$9.99$208,032-14.12%
2026-07-24PurchaseArtiva Biotherapeutics, Inc.
ARTV
41,319
0.1665%
$9.99$412,777-11.17%
2026-07-23PurchaseArtiva Biotherapeutics, Inc.
ARTV
59,880
0.2408%
$9.96$596,405-6.56%
2026-07-22PurchaseArtiva Biotherapeutics, Inc.
ARTV
84,124
0.3373%
$9.93$835,3510%
2026-07-21PurchaseArtiva Biotherapeutics, Inc.
ARTV
120,582
0.4659%
$9.55$1.15M+0.2%
2026-07-17PurchaseArtiva Biotherapeutics, Inc.
ARTV
7,882
0.0292%
$8.95$70,544+2.56%
2026-07-16SaleVor Biopharma Inc.
VOR
10 percent owner
213
0.0035%
$19.75$4,207+20.59%
2026-07-16PurchaseArtiva Biotherapeutics, Inc.
ARTV
152,472
0.6094%
$8.93$1.36M+10.62%
2026-07-13PurchaseArtiva Biotherapeutics, Inc.
ARTV
6,522
0.0264%
$8.94$58,307+10.19%
2026-07-10PurchaseArtiva Biotherapeutics, Inc.
ARTV
15,102
0.0569%
$8.97$135,465+1.24%
2026-06-26PurchaseArtiva Biotherapeutics, Inc.
ARTV
1,876
0.0071%
$8.98$16,846-0.26%
2026-06-25PurchaseArtiva Biotherapeutics, Inc.
ARTV
31,000
0.1261%
$8.88$275,280+8.83%
2026-06-17SaleWerewolf Therapeutics, Inc.
HOWL
10 percent owner
416,911
0.8729%
$0.35$145,919+161.63%
2026-06-16PurchaseArtiva Biotherapeutics, Inc.
ARTV
124,893
0.4893%
$8.89$1.11M+7.86%
2026-06-16SaleWerewolf Therapeutics, Inc.
HOWL
10 percent owner
149,625
0.2929%
$0.37$55,361+147.22%
2026-06-15PurchaseArtiva Biotherapeutics, Inc.
ARTV
15,414
0.0611%
$8.99$138,572+4.52%
Total: 212
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.